UPDATE 2-Europe stocks inch higher on UK merger action

(For a live blog on European stocks, type LIVE/ in an Eikon
news window)
* LSE touches record on possible deal to buy Refinitiv
* Just Eat soars on Takeaway.com deal report
* Sanofi up after raising 2019 outlook

(Updates to close)
By Sruthi Shankar and Medha Singh
July 29 (Reuters) - European stocks ground out a tiny gain
on Monday, as a pair of big merger reports and a weak pound sent
London's FTSE 100 higher, while defensive plays dominated other
major markets ahead of Wednesday's U.S. Federal Reserve policy
decision.
Shares in London Stock Exchange Group LSE.L itself surged
15.3% to an all-time high, the bourse operator's strongest
one-day performance as a company since late 2008 after it said
it was in discussions to buy Refinitiv Holdings for $27 billion,
including debt. That, along with a 22.7% jump for Just Eat shares JE.L
after rival online food delivery firm Takeaway.com TKWY.AS
agreed to buy the company in an 8.2-billion-pound ($10.1
billion) deal, helped the FTSE to an 11-month high. The exporter-heavy index also drew support from a slide in
sterling on a perceived rise in the chances of Britain exiting
the European Union without a deal under new Prime Minister Boris
Johnson. .L GBP/
Ireland's main stock index ISEQ .ISEQ , which has tended to
fall on fears of a disorderly Brexit, skidded 0.9%.
"The FTSE has just struck upon a bounty of news, be it Just
Eat and LSE deals and the pound falling off a cliff, it's very
much in a bubble at the moment compared to the rest of the
markets," said Connor Campbell, financial analyst at Spreadex in
London.
"There are still things to be found out on Wednesday from
the Fed. That may be why markets are just holding back a bit."
The pan-European stocks benchmark index .STOXX was up just
0.03%, with sectors such as real estate .SX86P and utilities
.SX6P gaining as investors favoured dividend-yielding names in
expectation that interest rates globally are about to fall.
The Fed is widely predicted to cut rates by a 25 basis point
for the first time in a decade on Wednesday, but investors will
be watching its statement for clues on whether that is just the
start of new cycle of easing by the U.S. central bank.
Global stock markets have recovered from a deep selloff in
May on hopes that major central banks would cut rates to support
global growth, as the pain from a prolonged U.S.-China trade war
mounts.
Officials from both sides will meet in Shanghai this week
for their first in-person talks since a G20 truce last month,
but expectations for a breakthrough are low. Trade-sensitive
auto stocks .SXAP fell 0.8%, the most among the major sectors.
Healthcare stock were mixed with Sanofi SASY.PA rising
1.5% after boosting its 2019 outlook, while Novartis NOVN.S
dropped 1.0% as a trial for a new use of its Entresto heart drug
failed. Heineken HEIO.AS dropped 4.6% after the world's second
largest brewer missed estimates for first-half profit.
Europe's largest low-cost carrier Ryanair RYA.I slipped
1.4% after reporting a sharp profit fall in the first half of
its key summer period. It said it may have to curb its growth
plans further if Boeing's BA.N schedule for returning the 737
MAX jet to service continues to slip.